Author

Carlos Lodeiro

LAQV RequimteORCID 0000-0001-5582-5446Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:proteomics· 3 Research Focus:differential expression· 2 Approach:statistical model· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Hugo Miguel SantosiD· 3 shared José Luís CapeloiD· 3 shared Luís B. CarvalhoiD· 3 shared André Q. FigueiredoiD· 2 shared Gianluca MoronciniiD· 2 shared Inês F. DomingosiD· 2 shared Jacek R. WiśniewskiiD· 2 shared Rajiv DhiriD· 2 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

Hugo Miguel SantosORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BiochemistrybioRxivPreprintOct 14, 2026

To Recover or Not to Recover: A Urinary Proteomic Perspective on Severe Acute Kidney Injury

André Q. Figueiredo, Inês F. Domingos, Sílvia Coelho…·Hugo Miguel Santos

This study evaluates a urinary FABP3/APOA1 ratio as a predictor of renal recovery after severe AKI, showing high accuracy in both discovery and validation cohorts.

DOI 10.64898/2026.10.12.758641

humanproteomics

𝕏 PostBluesky

BiochemistrybioRxivPreprintJul 17, 2026

Absolute quantitative proteomics guides patient-stratified drug repurposing in clear cell and papillary renal cell carcinoma.

André Q. Figueiredo, Inês F. Domingos, Carlos Lodeiro…·José Luís Capelo

This paper uses absolute quantitative proteomics to identify patient-specific drug repurposing strategies for clear cell and papillary renal cell carcinoma.

DOI 10.64898/2026.07.17.738718

humanproteomics

𝕏 PostBluesky

BiochemistrybioRxivPreprintNov 25, 2024

AI-driven Classification of Heart Failure Preserved and Reduced Ejection Fraction Patients Using the Total Protein Approach

Alessio Lenzi, Luís B. Carvalho, Pedro A.D. Teigas-Campos…·Hugo Miguel Santos

This study uses AI and mass spectrometry to identify biomarkers distinguishing HFpEF and HFrEF patients using the Total Protein Approach.

1 citation

humanproteomics

𝕏 PostBluesky